Plain-English translation of NCT07737171 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Cancer research guide →This is a 7-year study that collects information from patients who receive endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) — a procedure where doctors use an ultrasound camera passed down your throat to deliver heat directly to abnormal pancreatic tissue. Researchers want to understand how safe and effective this minimally invasive treatment is for pancreatic lesions, including cancers and precancerous growths.
Pancreatic cancer is very serious and traditional treatments can be difficult on patients. This study exists to see whether this newer, less invasive heat-based approach might be a safer or more effective option for people with pancreatic tumors or precancerous lesions.
You likely qualify if…
You likely don't qualify if…
If you are already receiving EUS-RFA treatment for your pancreatic lesion, you would be enrolled in this registry study, which means researchers will carefully track and document your treatment outcomes, any side effects, and your recovery over a 7-year period. You will likely have scheduled follow-up visits and imaging tests to monitor how well the treatment worked. The study does not ask you to do anything beyond your standard medical care — it simply collects data to help doctors understand how safe and effective this procedure is.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
United States
Sponsor
The University of Texas Health Science Center, Houston
Enrollment target
~60 participants
Started
April 2026
Primary completion
April 2033
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Amatullah Alibhai, MBA
The University of Texas Health Science Center at Houston (UTHealth Houston)
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.